Correlation Between Cadrenal Therapeutics, and Zivo Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Zivo Bioscience, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Zivo Bioscience.

Diversification Opportunities for Cadrenal Therapeutics, and Zivo Bioscience

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cadrenal and Zivo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Zivo Bioscience

If you would invest  1,423  in Cadrenal Therapeutics, Common on December 28, 2024 and sell it today you would earn a total of  423.00  from holding Cadrenal Therapeutics, Common or generate 29.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Cadrenal Therapeutics, Common  vs.  Zivo Bioscience

 Performance 
       Timeline  
Cadrenal Therapeutics, 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Zivo Bioscience 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Cadrenal Therapeutics, and Zivo Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cadrenal Therapeutics, and Zivo Bioscience

The main advantage of trading using opposite Cadrenal Therapeutics, and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.
The idea behind Cadrenal Therapeutics, Common and Zivo Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device